Iron Status and Cardiopulmonary Physiology
Iron-deficiency, Ventricular Function, Pulmonary Vascular Resistance Abnormality
About this trial
This is an interventional basic science trial for Iron-deficiency
Eligibility Criteria
Inclusion Criteria:
- Healthy non-pregnant adults
- Age 18-55 years
- Serving in the UK Armed Forces
- Selected for a military mountaineering team intending to climb to very high altitude
Exclusion Criteria:
- Diabetes
- Any cardiovascular or respiratory illness
- Regular medication which would interfere with any outcome measures in the study
- Pregnancy
Any condition which precludes the administration of Ferinject:
(i) hypersensitivity to the active substance, to Ferinject® or any of its excipients (ii) known serious hypersensitivity to other parenteral iron products (iii) microcytic anaemia not attributable to iron deficiency (e.g. sickle cell anaemia) (iv) evidence of iron overload or disturbances in the utilisation of iron.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Iron
Saline control
Received a blinded single 15 mg/kg dose of iv ferric carboxymaltose (Ferinject) up to a maximum off 1g total dose 2 weeks prior to ascent to very high-altitude.
Received a blinded single dose of iv normal saline 2 weeks prior to ascent to very high-altitude.